BOTULINUM TOXIN TYPE A FOR TREATMENT OF MYOGENIC PAIN IN TEMPOROMANDIBULAR DISORDERS - AN INTEGRATIVE LITERATURE REVIEW

Authors

DOI:

https://doi.org/10.47820/recima21.v4i11.4394

Keywords:

Botulinum Toxin Type A, Pain, Temporomandibular Disorder, Treatment

Abstract

Botulinum toxin type A (BoNT/A) has been increasingly used in dentistry, either for aesthetic or therapeutic use, and a recent indication is for the treatment of myogenic pain in temporomandibular disorders (TMD). This integrative review of the literature aimed to compile scientific evidence on the effectiveness of this application of BoNT/A in myofascial pain symptomatology associated with TMD. After applying the inclusion and exclusion criteria, 13 scientific articles were selected to discuss the theme. The publications show the clear potential of BoNT/A to be among the therapeutic options for myogenic symptoms of TMD. However, this review revealed weaknesses in the understanding of pharmacokinetics and pharmacodynamics, in the choice of target anatomical sites, in doses and dosage, and in tissue adaptations to the presence of the drug. These are answers that future studies should aim at, but conditioned to the implementation of basic scientific precepts, such as the standardization of therapeutic protocols and investigative consensus.

Downloads

Download data is not yet available.

Author Biographies

Andressa Di Donato Martini Reis

Centro Universitário de Patos de Minas - UNIPAM.

Adriane de Fátima Vieira

Graduanda do curso de Odontologia pelo Centro Universitário de Patos de Minas.

Antônio Afonso Sommer

Doutor em Ortodontia e docente do Centro Universitário de Patos de Minas.

References

AL-WAYLI, H. Treatment of chronic pain associated with nocturnal bruxism with botulinum toxin. A prospective and randomized clinical study. Journal of Clinical and Experimental Dentistry, v. 9, n. 1, p. 112-117, jan. 2017.

BEAUMONT, S. et al. Temporomandibular Disorder: a practical guide for dental practitioners in diagnosis and management. Aust Dent J, v. 65, n. 3, p. 172-180, set. 2020. Disponível em: https://pubmed.ncbi.nlm.nih.gov/32562281/. Acesso em: 27 fev. 2023.

BLANCO-RUEDA, J. A. et al. Preliminary Findings of the Efficacy of Botulinum Toxin in Temporomandibular Disorders: Uncontrolled Pilot Study. Life, v. 13, n. 2, p. 345, jan. 2023.

BORGES, R. N.; AVILA, M. Estudo da topografia do músculo esfenomandibular. Stomatos. v. 18, n. 35, p. 3-8, 2012.

BUCHAIM, R. L.; ISSA, J. P. M. Manual de anatomia odontológica. São Paulo: Manole, 2018. E-book. ISBN 9788520462331. Disponível em: https://integrada.minhabiblioteca.com.br/#/books/9788520462331/. Acesso em: 10 abr. 2023.

CANALES, G. D. L. T. et al. Efficacy of Botulinum Toxin Type-A I in the Improvement of Mandibular Motion and Muscle Sensibility in Myofascial Pain TMD Subjects: A Randomized Controlled Trial. Toxins, v. 14, n. 7, p. 441, jun. 2022.

CARVALHO, M. F. de.; ALCÂNTARA, A. P. S. de L. Utilização da toxina botulínica em desordens temporomandibulares: uma revisão sistemática. Brazilian Journal of Health Review, v. 3, n. 6, p. 19160–19168, 2020. Disponível em: https://ojs.brazilianjournals.com.br/ojs/index.php/BJHR/article/view/21996. Acesso em: 13 fev. 2023.

CHAURAND, J. et al. Efficacy of botulinum toxin therapy in treatment of myofascial pain. Journal of Oral Science, v. 59, n. 3, p. 351–356, 2017.

CRUZ, J. H. de A. et al. Disfunção temporomandibular: revisão sistematizada. Archives of Health Investigation, v. 9, n. 6, p. 570–575, 2020. Disponível em: https://www.archhealthinvestigation.com.br/ArcHI/article/view/3011. Acesso em: 13 fev. 2023.

DWORKIN, S. F. et al. Perspectives on the interaction of biological, psychological and social factors in TMD. Journal of the American Dental Association, v. 125, n.7, p. 856-863, 1994. Disponível em: https://pubmed.ncbi.nlm.nih.gov/8040536/. Acesso em: 07 mar. 2023.

FASSINA, M. T. et al. Toxina botulínica tipo A nas DTM musculares: há eficácia? Revista Metodista, São Paulo, v. 24, n. 8, 26 jul. 2017. Disponível em: https://www.metodista.br/revistas/revistasmetodista/index.php/Odonto/article/view/6881. Acesso em: 13 fev. 2023.

FLEUR, P.; ADAMS, A. Botulinum Toxin for Temporomandibular Disorders: A Review of Clinical Effectiveness, Cost-Effectiveness, and Guidelines. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health, 2020.

FREUND, B. et al. Botulinum toxin: new treatment for temporomandibular disorders. The British journal of oral & maxillofacial surgery, v. 38, n. 5, p. 466-71, 2000. Disponível em: https://pubmed.ncbi.nlm.nih.gov/11010775/. Acesso em: 13 fev. 2023.

GHAVIMI, M. A. et al. Effect of injection of botulinum toxin on decreasing the symptoms and signs of masticatory muscles in patients with temporomandibular dysfunction. Journal of Dental Research, Dental Clinics, Dental Prospects, v. 13, n. 2, p. 128–132, 14 ago. 2019.

HÄGGMAN-HENRIKSON, B. et al. Pharmacological treatment of orofacial pain – health technology assessment including a systematic review with network meta-analysis. J Oral Rehabil, v. 44, n. 10, p. 800-826, 2017.

HOSGOR, H.; ALTINDIS, S. Efficacy of botulinum toxin in the management of temporomandibular myofascial pain and sleep bruxism. Journal of the Korean Association of Oral and Maxillofacial Surgeons, v. 46, n. 5, p. 335–340, Out. 2020.

HUAMANI, M. A. U. et al. Use of botulinum toxin type a in temporomandibular disorder. RGO - Revista Gaúcha de Odontologia, v. 65, n. 2, p. 151–155, jun. 2017.

MACHADO, J. V. S.; ZANIN, M. R. D’O. O uso da toxina botulínica tipo-A em pacientes com DTM. Repositório UNITAU, Taubaté, 3 nov. 2020. Disponível em: http://repositorio.unitau.br/jspui/handle/20.500.11874/4074. Acesso em:13 fev. 2023.

MEZEY, S. E. et al. Yhe human masseter muscle revisited: First description of its coronoid part. Annals of Anatomy v. 240, 2022. Disponível em https://elsevier.sciencedirectassets.com. Acesso em: 21 out. 2023.

MILANO, V. et al. Magnetic resonance imaging of temporomandibular disorders: classification, prevalence and interpretation of disc displacement and deformation. Dentomaxillofac Radiol, v. 29, p. 352-361, 2000. Disponível em: https://pubmed.ncbi.nlm.nih.gov/11114665/. Acesso em: 08 mar. 2023.

MONGINI, F. ATM e Músculos Craniocervicofaciais: Fisiopatologia e tratamento. São Paulo: Santos, 1998.

MONTES-CARMONA, J.-F.; GONZALEZ-PEREZ, L.-M.; INFANTE-COSSIO, P. Treatment of Localized and Referred Masticatory Myofascial Pain with Botulinum Toxin Injection. Toxins, v. 13, n. 1, p. 6, 23 Dez. 2020.

MUNCHAU, A.; BHATIA, K. P. Uses of botulinum toxin injection in medicine today. BMJ: British medical journal / British Medical Association, v. 320, n. 7228, p.161-165, 2000.

MURRAY, G. M. et al. The human lateral pterygoid muscle. Arch Oral Biol, v. 52, n. 4, p. 377-380, 2007.

NAGATA, K. et al. Efficacy of mandibular manipulation technique for temporomandibular disorders patients with mouth opening limitation: a randomized controlled trial for comparison with improved multimodal therapy. J Prosthodont Res, v. 63, n. 2, p. 202-209, 2019.

PETROLLI, G. de O. P. et al. Tratamento de disfunções temporomandibulares com toxina botulínica tipo A. RFO UPF, p. 236–241, 2018.

PIHUT, M.; PAC, A.; GALA, A. Frequency of occurrence of the pain form of the temporomandibular disorders and gender distribution. Folia Med Cracov, v. 61, n. 2, p. 25-33, 2021.

PINTO, M. V. de M. et al. Análise dos deslocamentos do disco articular da articulação temporomandibular: revisão de literatura, critérios e exame. Fisioter Bras, v. 13, n. 2, p.142-147, mar./abr. 2012. Disponível em: https://pesquisa.bvsalud.org/portal/resource/pt/lil-764309. Acesso em: 23 mar. 2023.

RAMOS-HERRADA, R. M. et al. Effects of botulinum toxin in patients with myofascial pain related to temporomandibular joint disorders: A systematic review. Dental and Medical Problems, v. 59, n. 2, p. 271–280, 2022.

REZAZADEH, F. et al. The effects of botulinum toxin A injection on the lateral pterygoid muscle in patients with a painful temporomandibular joint click: a randomized clinical trial study. BMC oral health, v. 22, n. 1, p. 217, 31 maio 2022.

RILEY, P. et al. Oral splints for patients with temporomandibular disorders or bruxism: a systematic review and economic evaluation. Health Technol Assess, v. 24, n. 7, p. 1- 224, 2020.

RIZZATTI-BARBOSA, C. M.; ANDRADE, E. D. de. Uso de Medicamentos no Tratamento das Disfunções Temporomandibulares. In: Terapêutica medicamentosa em odontologia. 3. ed. São Paulo: Editora Artes Médicas Ltda, 2014. p. 149-154.

SALES, J. M. et al. Toxina botulínica como opção no tratamento da disfunção temporomandibular. Revista Salusvita, Bauru, v. 39, p. 229-254, 7 jun. 2020. Disponível em: https://secure.unisagrado.edu.br/static/biblioteca/salusvita/salusvita_v39_n1_2020/salusvita_v39_n1_2020_art_17.pdf. Acesso em: 13 fev. 2023.

SMALL, R.; HOANG, D. Guia prático de Procedimentos com Toxina Botulínica. Rio de Janeiro: Di Livros Editora, 2013.

SOUZA, I. L. B. de; NAHES, C. R.; PIERRI, J. de. Desordens dos músculos mastigatórios / Masticatory muscle disorders. Brazilian Journal of Development, v. 6, n. 7, p. 48233-48238, 2020.

SPOSITO, M. M. de M. Toxina Botulínica do Tipo A: mecanismo de ação. Acta Fisiátr, São Paulo, v. 16, n. 1, p. 25-37, 9 mar. 2009. Disponível em: https://www.revistas.usp.br/actafisiatrica/article/view/103037. Acesso em: 13 fev. 2023.

TALAAT, W. M.; ADEL, O. I.; AL BAYATTI, S. Prevalence of temporomandibular disorders discovered incidentally during routine dental examination using the Research Diagnostic Criteria for Temporomandibular Disorders. Oral Surg Oral Med Oral Pathol Oral Radiol., v. 125, n. 3, p. 250-259, 2017.

VILAR, E. G. S. et al. Indicações cirúrgicas de deslocamento do disco articular da articulação temporomandibular. Brazilian Journal of Health Review, v. 3, n. 5, p. 13790-13809, 2020.

YULE, P. L.; DURHAM, J.; WASSELL, R. W. Pain Part 6: Temporomandibular disorders. Dent Update, v. 43, n. 1, p. 39-48, 2016.

Downloads

Published

21/11/2023

How to Cite

Donato Martini Reis, A. D., de Fátima Vieira, A., & Afonso Sommer, A. (2023). BOTULINUM TOXIN TYPE A FOR TREATMENT OF MYOGENIC PAIN IN TEMPOROMANDIBULAR DISORDERS - AN INTEGRATIVE LITERATURE REVIEW. RECIMA21 - Revista Científica Multidisciplinar - ISSN 2675-6218, 4(11), e4114394. https://doi.org/10.47820/recima21.v4i11.4394

Issue

Vol. 4 No. 11 (2023): CLICK HERE TO ACCESS THE ARTICLES

Section

ARTIGOS

Categories

License

Copyright (c) 2023 RECIMA21 - Revista Científica Multidisciplinar - ISSN 2675-6218

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Os direitos autorais dos artigos/resenhas/TCCs publicados pertecem à revista RECIMA21, e seguem o padrão Creative Commons (CC BY 4.0), permitindo a cópia ou reprodução, desde que cite a fonte e respeite os direitos dos autores  e contenham menção aos mesmos nos créditos. Toda e qualquer obra publicada na revista, seu conteúdo é de responsabilidade dos autores, cabendo a RECIMA21 apenas ser o veículo de divulgação, seguindo os padrões nacionais e internacionais de publicação.